← Back to CAI

Caris Life Sciences, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 05/08/2026Mar 2026Filed 08/05/2026Sep 2025Filed 05/11/2025Jun 2025Filed 05/08/2026Mar 2025Filed 08/05/2026Sep 2024Filed 05/11/2025Jun 2024Filed 12/08/2025
$264$216$217$181$121$102$100
−$0.6−$0.5$24−$72−$103−$68−$66
$0.00$0.00$0.08−$7.97−$3.57−$2.59−$2.54
28328329765363635

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.